Promotion of Prescription Drugs to Consumers and Providers, 2001-2010 (2013)

Peer-Reviewed Study · Kornfield R, Donohue J, Berndt ER, Alexander GC · March 4, 2013

Kornfield R et al., 2013-03-04: Analysis of industry promotional spending: total promotion peaked at $36.1 billion in 2004 and fell to $27.7 billion (9.0% of sales) by 2010, with provider-directed promotion and direct-to-consumer advertising each down about 25% from 2006.

By 2010 it had declined to $27.7B (9.0% of sales).

Abstract, Results

Kornfield R et al., 2013-03-04: Analysis of industry promotional spending: total promotion peaked at $36.1 billion in 2004 and fell to $27.7 billion (9.0% of sales) by 2010, with provider-directed promotion and direct-to-consumer advertising each down about 25% from 2006. Funding: AHRQ grant R01 HS0189960 (Kornfield, Alexander); 'The funding sources had no role in study design…'. No drug maker funding. Comparator: promotional spend vs sales, 2001-2010. Total 2010 promotion ($27.7B) is well above the book's '$6 billion', but far below the $67.4B R&D figure (CHE-27), so the claim's comparison is wrong in direction; $6B may reflect physician detailing alone, not total promotion.